Other languages ImpediMed Limited

Equities

Delayed Australian S.E. Other stock markets 02:10:05 2024-04-29 EDT			5-day change	1st Jan Change
0.089 ^AUD	+3.49%		-1.11%	-38.62%

04-17	Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	MT
04-17	Ord Minnett Starts ImpediMed at Speculative Buy, Price Target is AU$0.16	MT

ImpediMed to Present Chronic Breast Cancer-Related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting	04-11
Impedimed Names Independent Non-Executive Chair	02-27
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	02-26
ImpediMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-26
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	02-14
ImpediMed CEO, CFO Step Down; Shares Fall 11%	11-19
ImpediMed Limited Announces CEO Changes	11-19
ImpediMed Limited Announces Management Changes	11-19
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	11-02
ImpediMed Limited Announces Resignation of Mrs. Janet West AM as Non-Executive Director	23-10-02
Impedimed Limited Announces Board Changes	23-09-28
ImpediMed Appoints Medical Chief; Shares Down 3%	23-09-26
ImpediMed Limited Announce the Appointment of Steven Chen as Chief Medical Officer	23-09-26
Impedimed Widens Fiscal 2023 Loss; Shares Down 3%	23-08-31
ImpediMed Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30
ImpediMed Limited Shareholders Received a Letter from the Board	23-08-16
ImpediMed Limited Receives Notice from Acadia Park Pty Ltd	23-08-02
ImpediMed Limited Receives Notice from Acadia Park Pty Ltd	23-08-02
ImpediMed Limited Receives Notice from Acadia Park Pty Ltd to Remove Directors	23-07-30
ImpediMed Limited Appoints Daniel Sharp as Director	23-07-03

No results for this search